Attachment F

Attachment F.2 Cover letter for DDI Health Clinic leadership survey.doc

Assessing the Diabetes Detection Initiative for Policy Decisions

Attachment F

OMB: 0920-0791

Document [doc]
Download: doc | pdf

Date



Name

Clinic Name

Address 1

City State Zip


Dear [Name]:


We are asking all clinics that participated in the implementation of the Diabetes Detection Initiative (DDI) to complete the enclosed survey. The DDI was launched in November of 2003 as a national pilot to mobilize community-based efforts targeted toward identifying a portion of the estimated 5 million people with undiagnosed Type 2 diabetes, refer them for diagnostic testing and, if appropriate, follow-up treatment. The purpose of this survey is to obtain information regarding the costs associated with your clinic’s current activities in the areas of diabetes awareness and screening, as well as the number of patients screened or diagnosed.


The survey is part of a research study funded by the Centers for Disease Control and Prevention (CDC). CDC has asked Battelle, a non-profit research group, to do the survey for this study. The survey has questions about the medical costs of providing patient care in the clinic, as well as staff time associated with patient outreach activities.


Completion of this survey is voluntary. You may leave any questions blank that you cannot or do not wish to answer, though we hope you will answer as many questions as you can. Your name will not be on the survey and your answers will not be linked to your name. All information we get in this study will be kept secure according to federal laws. Data collected from this survey will be grouped with others answers and reported only in aggregate form so no single respondents answers can be identified. The survey may take up to an hour to complete as you may need to look up information in your records in order to respond to some questions. You will not benefit directly from taking part in this survey; however, the survey will provide the Centers for Disease Control with some of the answers they need in planning and evaluating diabetes screening programs.


If you have any questions about the study, please call us. The task leader for this study, Diane Manninen, PhD can be reached at (206) 528-3140. If you have any concerns about your rights in being part of this study, you may call the Chairperson of the Battelle Institutional Review Board at 1-877-810-9530, extension 500.


Thank you for your time.


Sincerely,



Diane Manninen, PhD

Battelle

Centers for Public Health Research and Evaluation


File Typeapplication/msword
File TitleDate
AuthorBattelle
Last Modified ByBattelle
File Modified2007-12-20
File Created2007-12-20

© 2024 OMB.report | Privacy Policy